4 November 2026RSS feed
PR●Press Release IndiaTHE BUSINESS ANNOUNCEMENT WIRE
Business announcements.
Direct from the source.
NEWSROOM / INDIA

The latest on the wire

Announcements from businesses shaping what comes next.

UPDATED THROUGHOUT THE DAY
Business wire17249

Takeda Announces Publication of Data from SOLSTICE, a Pivotal Phase 3 Trial for LIVTENCITY™ (Maribavir) in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)

Results Of The Global Phase 3 Trial, Now Published In Clinical Infectious Diseases, Show For The Primary Endpoint, LIVTENCITY Was Statistically Superior To Conventional Therapies At Study Week 81 For The Key Secondary Endpoint, LIVTENCITY Was Statistically Sig